Carlton Hofferkamp & Jenks Wealth Management LLC lowered its stake in shares of CVS Health Corp (NYSE:CVS) by 15.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,708 shares of the pharmacy operator’s stock after selling 2,577 shares during the quarter. Carlton Hofferkamp & Jenks Wealth Management LLC’s holdings in CVS Health were worth $993,000 at the end of the most recent reporting period.
Other hedge funds have also modified their holdings of the company. Fieldpoint Private Securities LLC boosted its stake in CVS Health by 333.3% during the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $105,000 after purchasing an additional 1,000 shares during the last quarter. Wealthcare Advisory Partners LLC lifted its position in shares of CVS Health by 330.3% during the 3rd quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock worth $105,000 after buying an additional 991 shares in the last quarter. Arcadia Investment Management Corp MI lifted its position in shares of CVS Health by 119.6% during the 3rd quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after buying an additional 726 shares in the last quarter. MPS Loria Financial Planners LLC bought a new stake in shares of CVS Health in the 2nd quarter worth approximately $119,000. Finally, Cerebellum GP LLC bought a new stake in shares of CVS Health in the 4th quarter worth approximately $130,000. 84.12% of the stock is currently owned by hedge funds and other institutional investors.
In other news, EVP Lisa Bisaccia sold 29,445 shares of the business’s stock in a transaction dated Thursday, December 21st. The shares were sold at an average price of $75.00, for a total value of $2,208,375.00. Following the completion of the sale, the executive vice president now owns 15,556 shares in the company, valued at approximately $1,166,700. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Helena Foulkes sold 19,965 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $71.04, for a total transaction of $1,418,313.60. Following the transaction, the executive vice president now owns 65,072 shares of the company’s stock, valued at approximately $4,622,714.88. The disclosure for this sale can be found here. 0.61% of the stock is owned by insiders.
A number of equities research analysts have issued reports on CVS shares. Raymond James Financial raised shares of CVS Health from an “outperform” rating to a “strong-buy” rating and set a $90.00 target price on the stock in a report on Thursday, January 4th. They noted that the move was a valuation call. Citigroup set a $76.00 price target on shares of CVS Health and gave the company a “hold” rating in a research report on Monday, December 4th. Jefferies Group set a $76.00 target price on shares of CVS Health and gave the stock a “hold” rating in a research report on Monday, December 4th. Leerink Swann set a $85.00 price target on shares of CVS Health and gave the company a “buy” rating in a research report on Monday, December 4th. Finally, Needham & Company LLC upped their price objective on shares of CVS Health from $79.00 to $85.00 and gave the company a “buy” rating in a research note on Monday, December 4th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. CVS Health has an average rating of “Buy” and a consensus price target of $87.03.
Shares of CVS Health Corp (CVS) traded down $1.30 during midday trading on Wednesday, reaching $66.95. 5,547,893 shares of the company’s stock were exchanged, compared to its average volume of 8,700,969. CVS Health Corp has a one year low of $66.45 and a one year high of $84.00. The company has a market cap of $68,020.00, a P/E ratio of 10.35, a P/E/G ratio of 1.14 and a beta of 1.03. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.52 and a current ratio of 1.02.
CVS Health (NYSE:CVS) last issued its quarterly earnings data on Thursday, February 8th. The pharmacy operator reported $1.92 EPS for the quarter, topping analysts’ consensus estimates of $1.88 by $0.04. The business had revenue of $48.39 billion during the quarter, compared to analysts’ expectations of $47.54 billion. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The business’s revenue was up 5.3% on a year-over-year basis. During the same period last year, the company posted $1.71 EPS. equities analysts anticipate that CVS Health Corp will post 6.37 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 3rd. Shareholders of record on Monday, April 23rd will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.99%. CVS Health’s dividend payout ratio (DPR) is 30.91%.
TRADEMARK VIOLATION WARNING: This piece was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://ledgergazette.com/2018/03/14/cvs-health-corp-cvs-shares-sold-by-carlton-hofferkamp-jenks-wealth-management-llc.html.
About CVS Health
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.